Periodoncia.Eley.6a.Ed

270 Periodoncia
Sande MA, Chambers HF, Kupusnik-Uner JE: Antimicrobial agents: Tetracyclines,
chloramphenicol, erythromycin and miscellaneous antibacterial agents. In Goodman-
Gilman A, Hardman JG, Limbird LE, Molinoff PB, Ruddon RE, editors: Goodman y
Gilman’s the Pharmacological Basis of Therapeutics, ed 9, New York, 1996, McGraw
– Hill, pp 1123–1154, Ch. 47 Section IX, Chemotherapy of microbial disease.
Satomi A, Vraguchi R, Ishikawa I, et al: Minocycline hydrochloride concentration in
periodontal pockets after administration of LS-007, J Assoc Periodontol 29:937–943,
1987.
Schaberg DR, Zervos MJ: Intergeneric and interspecies gene exchange in gram-positive
cocci, Antimicrob Agents Chemother 30:817–822, 1986.
Sher TH: Penicillin hypersensitivity, Rev Pediatr Clin North Am 30:161–176, 1983.
Shinn DL: Metronidazole in acute ulcerative gingivitis, Lancet 1:1191, 1962.
Shinn DL, Squires S, McFadzean JA: The treatment of Vincent’s disease with
metronidazole, Dent Pract 15:275–280, 1965.
Shlaes DM, Gerding DN, JohnJr JF, et al: Society for Healthcare Epidemiology of
America and Infectious Diseases Society of America. Joint Committee on the
Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial
resistance in hospitals, Clin Infect Dis 25:584–599, 1997.
Slots J, Rosling B: Suppression of periodontopathic microflora in localized juvenile
periodontitis by systemic tetracycline, J Clin Periodontol 10:465–486, 1983.
SMAC, Standing Medical Advisory Committee, Subgroup on Antimicrobial Resistance
1999 The path of least resistance Department of Health: London 17-19.Ch. 4,
Antimicrobial agents.
SMAC, Standing Medical Advisory Committee, Subgroup on Antimicrobial Resistance
1999 The path of least resistance Department of Health: London 20–23.Ch. 5, Basis of
resistance
SMAC, Standing Medical Advisory Committee, Subgroup on Antimicrobial Resistance
1999 The path of least resistance Department of Health: London 24Ch. 6, Does the use
of antimicrobial agents cause resistance?
SMAC, Standing Medical Advisory Committee, Subgroup on Antimicrobial Resistance
1999 The path of least resistance Department of Health: London 33–54.Ch.10, Current
resistance problems in the UK and worldwide.
Smith TC: ICAAC Abstract LB-16. ICAAC, Washington DC, 1997, American Society for
Microbiology, 11.
Soares S, Kristinsson KG, Musser JM, et al: Evidence for the introduction of a
multi-resistant clone of serotype 6B Streptococcus pneumoniae form Spain into Iceland
in the late 1980s, J Infect Dis 168:158–163, 1992.
Söder PÖ, Frithiof L, Wikner S, et al: The effect of systemic metronidazole after
non-surgical treatment in moderate and advanced periodontitis in young adults,
J Periodontol 61:281–288, 1990.
Soory M: A role for non-antimicrobial actions of tetracyclines in combating oxidative
stress in periodontal and metabolic diseases, The Open Dentistry Journal 2:5–12, 2008.
Sorsa T, Ding Y, Salo T, et al: Effects of tetracyclines on neutrophil, gingival and salivary
collagenases. A functional and western-blot assessment with special reference to their
cellular sources in periodontal diseases, Ann N Y Acad Sci 732:112–131, 1994.
Speer BS, Shoemaker NB, Salyers AA: Bacterial resistance to tetracycline: mechanisms,
transfer and clinical significance, Clin Microbiol Rev 5:387–399, 1992.
Speller DCE, Johnson AP, James D, et al: Resistance to methicillin and other antibiotics
in Staphylococcus aureus from blood and cerebrospinal fluid, England and Wales,
19891995, Lancet 350:323–325, 1997.
Spratt BG: Resistance to antibiotics mediated by targy alterations, Science 264:388–393,
1994.
Sprott MS, Ingham HR, Hickman JE, et al: Metronidazole resistant anaerobes, Lancet
8335:1230, 1983.
Stoltze K, Stellfeld M: Systemic absorption of metronidazole after application of a 25%
metronidazole dental gel, J Clin Periodontol 19:693–697, 1992.
Stoltze K: Concentration of metronidazole in periodontal pockets after application of a
25% metronidazole dental gel, J Clin Periodontol 19:698–701, 1992.
Surtees SJ, Stockton MG, Gietzen TW: Allergy to penicillin: fact or fiction, Br Med J
302:1051–1052, 1991.
Tenenbaum H, Jehl F, Gallion C, et al: Amoxicillin and clavulanic acid concentrations in
gingival crevicular fluid, J Clin Periodontol 24:804–807, 1997.
Theilade E: The non-specific theory in microbial etiology of inflammatory periodontal
diseases, J Clin Periodontol 13:905–911, 1986.
Threlfall EJ, Ward LR, Rowe B: Spread of multiresistant strains of Salmonella
typhimurium phage types 204 and 193 in Britain, Br Med J 2:997, 1978.
Threlfall EJ, Rowe B, Fergerson JL, et al: Increasing incidence of resistance to
gentamicin and related aminoglycosides in Salmonella typhimurium phage type 204c
in England, Wales and Scotland, Vet Rec 117:355–357, 1985.
Threlfall EJ, Rowe B, Fergerson JL, et al: Characterization of plasmids conferring
resistance to gentamicin and apramycin in strains of Salmonella typhimurium phage
types 204c isolated in Britain, J Hyg 97:419–426, 1986.
Threlfall EJ, Hall ML, Rowe B: Salmonella bacteraemia in England and Wales,
19811990, J Clin Pathol 45:34–36, 1992.
Threlfall EJ, Ward LR, Rowe B: A comparison of multiple drug resistance in salmonellas
from humans and food animals in England and Wales, 1981 and 1990, Epidemiol Infect
111:189–197, 1993.
Threlfall EJ, Frost JA, Ward L, et al: Increasing spectrum of resistance in multiresistant
Salmonella typhimurium, Lancet 347:1053–1054, 1996.
Timmerman MF, van der Weijden GA, van Steenbergen TJM, et al: Evaluation of the
long-term efficacy and safety of locally-applied minocycline in adult periodontitis
patients, J Clin Periodontol 23:707–716, 1996.
Todd PA, Benfield P: Amoxycillin/clavulanic acid. An update of its antibacterial activity,
pharmokinetic properties and therapeutic use, Drugs 39:264–307, 1990.
Tonetti MS: Etiology and pathogenesis. In Lang NP, Karring T, editors: In Proceedings of
the 1st European Workshop on Periodontology, Berlin, Germany, 1994, Quintessence
Publishing, pp 54–89.
Tonetti MS: Local delivery of tetracycline: from concept to clinical application, J Clin
Periodontol 25:969–977, 1998.
Tonetti MS, Cugini MA, Goodson JM: Zero-order delivery with periodontal placement
of tetracycline-loaded ethylene vinyl acetate fibres, J Periodontal Res 25:243–249,
1990.
Tonetti MS, Mombelli A, Lehmann B, et al: Impact of oral ecology on the recolonisation
of locally treated pockets, J Dent Res 74:481, 1995, Abstract 642.
Tracey JW, Webster LT: Trypanosomiasis, Leishmaniasis, Amebiasis, Giardiasis,
Trichomoniasis and other protozoal infections. In Goodman-Gilman A, Hardman
JG, Limbird LE, Molinoff PB, Ruddon RE, editors: Goodman y Gilman’s the
Pharmacological Basis of Therapeutics, ed 9, New York, 1996, McGraw-Hill,
pp 987–1008, Ch. 41 Section IX, Chemotherapy of microbial disease.
Vandekerckhove BN, Quirynen M, van Steenberghe D: The use of locally-delivered
minocycline in the treatment of chronic periodontitis. A review of the literature, J Clin
Periodontol 25:964–968, 1998.
van Palenstein Helderman WH: Is antibiotic therapy justified in the treatment of human
chronic inflammatory periodontal disease? J Clin Periodontol 13:932–938, 1986.
Van Steenberge D, Bercy P, Hohl J, et al: Subgingival minocycline hydrochloride
ointment in moderate to severe chronic adult periodontitis: randomised, double-blind,
vehicle-controlled, multi-centre study, J Periodontol 64:637–644, 1993.
van Winkelhoff AJ, Rodenberg AJ, Goené RJ, et al: Metronidazole plus amoxicillin in the
treatment of Actinobacillus actinomycetemcomitans associated periodontitis, J Clin
Periodontol 16:128–131, 1989.
van Winkelhoff AJ, Herrera D, Oteo A, et al: Antimicrobial profiles of periodontal
pathogens isolated from periodontitis patients in the Netherlands and Spain, J Clin
Periodontol 32:893–898, 2005.
van Zwet AA, Thijs JC, Schievink-de Vries W, et al: In vitro studies on stability and
development of metronidazole resistance in Helicobacter pylori, Antimicrob Agents
Chemother 38:360–362, 1994.
Vorachit M, Lam K, Jayanetra P, et al: Resistance of Pseudomonas pseudomallei growing
on a biofilm on silastic discs to ceftazidime and co-trimoxazole, Antimicrob Agents
Chemother 37:2000–2002, 1993.
Wade AB, Blake GC, Mirza KB: Effectiveness of metronidazole in treating the acute
phase of ulcerative gingivitis, Dent Pract 16:440–443, 1966.
Wallace MR, Mascola JR, Oldfield EC: The red man syndrome: incidence, aetiology and
prophylaxis, J Infect Dis 164:1108–1185, 1991.
Walker CB, Gordon JM, Cornwall HA, et al: Gingival crevicular fluid levels of
clindamycin compared with its minimal inhibitory concentrations for periodontal
bacteria, Antimicrob Agents Chemother 19:867–871, 1981.
Walker CB, Gordon JM, McQulkin SJ, et al: Tetracycline: levels achievable in gingival
crevice fluid and in vitro effect on subgingival organisms. Part II Susceptibilities of
periodontal bacteria, J Periodontol 52:613–616, 1981.
Walker CB, Gordon JM, Socransky SS: Antibiotic sensitivity testing of subgingival
plaque samples, J Clin Periodontol 10:422–432, 1983.
Walker C, Nango S, Lennon J, et al: Effect of sub-antimicrobial dose doxycycline (SDD)
on the intestinal and vaginal flora, J Dent Res 79(Special Issue):, 2000, 608Abstract
3718.
Warburton AR, Jenkins PA, Waight PA, et al: Drug resistance in initial isolates of
Mycobacterium tuberculosis in England and Wales, 19821991, Commun Dis Rep CDR
Rev 3:R175–R179, 1993.
Wennström JL, Newman HN, Griffiths GS, et al: Utilisation of locally delivered
doxycycline in non-surgical treatment of chronic periodontitis. A comparative
multicenter trial of two treatment approaches, J Clin Periodontol 28:753–761, 2001.
Williams BL, Østerberg SK, Jørgensen J: Subgingival microflora of periodontal patients
on tetracycline therapy, J Clin Periodontol 6:210–221, 1979.
Williams RC, Paquette D, Offenbacher S, et al: Treatment of periodontitis by local
administration of a micro-encapsulated antibiotic: a controlled trial, J Periodontol
72:753–761, 2001a.
Williams RC, Paquette D, Offenbacher S, et al: Treatment of periodontitis by local
administration of minocycline microspheres, a controlled trial, J Periodontol
72:1535–1544, 2001b.
Woodford N, Johnson AP, Morrison D, et al: Current perspectives on glycopeptide
resistance, Clin Microbiol Rev 8:585–615, 1995.
Wright TL, Ellen RP, Lacriox JM, et al: Effects of metronidazole on Porphyromonas
gingivalis biofilms, J Periodontal Res 32:473–477, 1997.
Yu L, Smith G, Hasty K, et al: Doxycycline inhibits type XI collagenolytic activity of
extracts from human osteoarthritic cartilage and of gelatinase, J Rheumatol 18:1450–1452,
1991.
Yu Z, Ramamurthy NS, Leung M, et al: Chemically-modified tetracycline normalizes
collagen metabolism in diabetic rats: a dose response study, J Periodontal Res 28:420–
428, 1993.